Connect with us

Health

Pfizer To Appeal For US Immunization Endorsement For More Youthful Youngsters In November

Published

on

Chief signs aim to get authorisation for babies as youthful as a half year old

Pfizer said it expected to apply in November for US authorisation of its Covid-19 immunization for youngsters matured between a half year and five years of age as it competitions to extend qualification for the hit.

The antibody, created in organization with BioNTech, was quick to be approved for use in youngsters matured 12 and over, and Pfizer had as of now said it wanted to apply for endorsement from the US Food and Drug Administration for kids matured somewhere in the range of five and 11 years of age toward the beginning of October.

On Tuesday, Pfizer offered the primary look at its planned timetable for authorisation of the punch in newborn children as youthful as a half year old. Plain D’Amelio, CFO, told an industry meeting the organization would have liked to “go document” for this age bunch in November.

“We would hope to have . . . data for youngsters between the ages of a half year and five years of age that we would document with the FDA,” D’Amelio said. “I’ll call it in the weeks presently the recording of the information for the five-to 11-year-olds.”

Talking at the Morgan Stanley Global Healthcare Conference on Tuesday, D’Amelio added that the putative timetable expected “the entirety of the information is positive”.

Immunizing babies is viewed as a pivotal advance in subduing the pandemic given that childcare offices and schools can fill in as favorable places for the infection. Furthermore, rising Covid disease and hospitalization levels in the US have moved calls for antibodies to be made accessible for youngsters, particularly as schools resume for the pre-winter term.

In the week finishing August 14, the Covid hospitalization rate among kids matured four and under was almost multiple times the level of the week finishing June 26, as indicated by a report distributed last week by the Centers for Disease Control and Prevention.

Notwithstanding, as indicated by the latest information gathered in the US, the hospitalization rate among kids matured four or more youthful was simply 2.2 per 100,000, contrasted and 15.8 per 100,000 among the generally inoculated over-65s.

Scott Gottlieb, a Pfizer chief and previous FDA official, comprehensively affirmed the course of events given by D’Amelio. gathering on Tuesday, he said that administrative authorisation of the BioNTech/Pfizer hit in kids as youthful as possible come in “late 2021, mid 2022”.

The BioNTech/Pfizer poke for the most youthful youngsters is less intense than the others. In clinical preliminaries, kids matured between a half year and five years of age are given a 3 microgram immunization, contrasted and 10 micrograms for those matured five to 11 and 30 micrograms for grown-ups.

Health

Samsung’s Android Health App Has Been Updated

Published

on

Samsung’s Android Health App Has Been Updated, Allowing You to Monitor Your Drug Use on Your Smartphone

Samsung has simplified the way users maintain their medical records with a significant update to its official Health app for Android. With this upgrade, people can easily watch their daily food intake, manage their prescriptions, and access their medical history all from a single interface. Those who are treating chronic conditions including diabetes, hypertension, PCOS, and PCOD will especially benefit from this additional capacity, which makes it easier to stick to their medication regimens.

This feature’s customized design for Indian consumers is what sets it apart. To obtain thorough information, including descriptions, potential side effects, and crucial safety instructions, users only need to input the name of their prescription into the app. Furthermore, the app alerts users about potentially dangerous drug combinations.

Customized Medication Reminders

Users can also create customized reminders for medicine refills and ingestion through the Samsung Health app. These signals can be tailored to each person’s tastes, providing choices ranging from gentle prods to more forceful warnings. Reminders will appear right on the wrist of people who own a Galaxy Watch, making sure they remember to take their medications on time even when their phones are out of reach.

In addition to medication management, the Samsung Health app offers a number of cutting-edge health features, such as mindfulness training, sleep tracking, and heart rhythm alerts. Samsung further demonstrates its dedication to offering complete wellness solutions by launching this medication tracking feature in India, enabling customers to live longer, healthier lives.

Kyungyun Roo, the managing director of Samsung Research Institute in Noida, stated: The Managing director of Samsung Research Institute, Noida, Kyungyun Roo, said, “We aim to create a comprehensive health platform that allows people to better understand and control their health by integrating devices and services. With the addition of the Medications feature for India in the Samsung Health app, we hope users will be able to manage their medicines more conveniently, improve adherence and eventually maintain better health.”

The medication tracking feature will be incorporated into the Samsung Health app in India via app updates. As stated by the tech giant, the information offered is evidence-based and licensed by Tata 1mg. If the new feature isn’t visible, consider updating your Samsung Health app.

Continue Reading

Health

Consuming This Food During Pregnancy May Reduce Autism Risk by 20%, Study Finds

Published

on

A new study suggests that eating fish during pregnancy could reduce the risk of a child being diagnosed with autism spectrum disorder (ASD) by 20%. However, taking fish oil supplements did not have the same effect.

“This study adds to the growing evidence supporting the safety and benefits of regular fish consumption during pregnancy,” said Dr. Emily Oken, co-author of the study and professor at Harvard Medical School. “Other benefits include a lower risk of preterm birth and improved cognitive development.”

Health experts recommend that pregnant women consume 8 to 12 ounces of low-mercury seafood per week to support fetal brain development. Despite these guidelines, the study, led by researchers from Drexel University’s A.J. Drexel Autism Institute, found that about 25% of pregnant women didn’t eat any fish.

The study analyzed data from 10,800 pregnant women regarding their fish intake and 12,646 women who took fish oil supplements, looking for links to autism diagnoses and autism-related traits. The results showed that 65% to 85% of the participants did not take fish oil or omega-3 supplements.

Omega-3 fatty acids, essential for heart, brain, and eye function, are found in fish, walnuts, flax seeds, and leafy greens, but the body cannot produce them naturally. Interestingly, the study found that fish consumption during pregnancy was more strongly associated with a reduced autism risk in female children.

The researchers noted that omega-3 supplements did not show any association with autism diagnoses or related traits. Autism is a complex developmental disorder affecting behavior, communication, and social interaction, and its causes are not yet fully understood.

The findings, published in The American Journal of Clinical Nutrition, acknowledge some limitations, including the inability to specify which types of fish were eaten, the timing of consumption, or the omega-3 content of supplements. The researchers are urging clearer public guidance on the importance of eating fish during pregnancy.

Continue Reading

Health

Researchers Discuss how a Diet that Mimics Fasting may be used to Cure Cancer

Published

on

A diet that mimics fasting aids in limiting nutritional intake to produce an unfavorable environment for the proliferation of cancer cells, hence improving the effectiveness of cancer treatment.

Globally, medical professionals and researchers are never-ending in their hunt for cancer prevention strategies. They are always thinking ahead and looking for solutions to deal with the potentially fatal illness. A recent study has demonstrated the enormous potential of a diet that mimics fasting to enhance the effectiveness of cancer treatment. FMD, or fasting-mimicking diet, is a dietary pattern that permits a controlled food intake while simulating the physiological effects of fasting.

Scientists at the University of Milan carried out the investigation, and the findings were encouraging. The objective behind the study is to make cancer cells more susceptible to treatment by temporarily limiting their intake of specific nutrients and calories. Nonetheless, safeguarding the healthy cells is another aspect of this process.

Still, fasting as a cancer-fighting strategy is not brand-new. Researchers have been examining how specific nutrients are necessary for the growth and development of cancer cells for many years. Among these is glucose. Therefore, FMD employs the strategy of limiting the intake of these nutrients in order to provide an environment that is unfavorable to the proliferation of cancer cells.

How does FMD function?

A diet that mimics fasting has been found to have the ability to improve the outcomes of cancer treatments like immunotherapy, chemotherapy, and targeted medications. Primarily, it limits the consumption of specific nutrients that enhance the growth of cancer cells. Secondly, it increases the susceptibility of cancer cells to the effects of chemotherapy. Thirdly, it strengthens the immune system’s defenses against cancer, which amplifies the benefits of immunotherapy.

How can a diet simulating fasting be put into practice?

Numerous cancer types can benefit from a diet that mimics fasting. In order to produce an environment that is hostile to the growth of cancer cells, it aids in improving the body’s natural response and reducing nutrition intake. This increases the effectiveness of treatment.

Continue Reading

Trending

error: Content is protected !!